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Abstract
Objective.—Racial/ethnic differences with regard to complementary and alternative medicine
(CAM) use have been reported in the US. However, specific details of CAM use by African
Americans with rheumatoid arthritis (RA) are lacking.
Methods.—Data were collected from African Americans with RA enrolled in a multicenter
registry regarding the use of CAM, including food supplements, topical applications, activities,
and alternative care providers. Factors associated with CAM use by sex and disease duration were
assessed using t-test, Wilcoxon’s rank sum test, chi-square test, and logistic regression analyses.
Results.—Of the 855 participants, 85% were women and mean age at enrollment was 54 years.
Overall, ever using any of the CAM treatments, activities, and providers was 95%, 98%, and 51%,
respectively (median of 3 for number of treatments, median of 5 for activities, and median of 1 for
providers). Those with longer disease duration (>2 years) were significantly more likely (odds
ratio >2.0, P < 0.05) to use raisins soaked in vodka/gin, to take fish oils, or to drink alcoholic
beverages for RA treatment than those with early disease. As compared to men, women were
significantly (P < 0.05) more likely to pray/attend church, write in a journal, and use biofeedback,
but were less likely to smoke tobacco or topically apply household oils for treatment of RA.
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Conclusion.—CAM use was highly prevalent in this cohort, even in individuals with early
disease. Health care providers need to be aware of CAM use as some treatments may potentially
have interactions with conventional medicines. This could be important within this cohort of
African Americans, where racial disparities are known to affect access to conventional care.
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic multisystem autoimmune disease associated with
severe morbidity if untreated. Despite early detection and availability of treatments to slow
disease progression, no definitive cure exists for RA. Current treatment modalities often
have side effects that may affect quality of life (1). Additionally, RA also has a significant
impact on emotional and social well-being (2). These factors are potential contributing
factors to use of treatments in place of (alternative) or in addition (complementary) to
conventional medications.
In the US, complementary and alternative medicine (CAM) use has been increasing in
general and for arthritis, including RA. The prevalence of CAM use in RA patients has been
reported to vary from 20% to 86% (3-6). The 2007 National Health Interview Survey
(NHIS) (3) reported that 4 of 10 US adults had used CAM therapy in the past 12 months.
Between 2002 and 2007, the relative increase in CAM use (including prayer for health
reasons) was 14.2% (4).
The 2002 and 2007 NHIS revealed a clear pattern of CAM use among different racial/ethnic
groups, with non-Hispanic whites and Asian Americans being more likely to use CAM than
African Americans and Hispanics (3-5). With regard to prayer, African Americans were
more likely to pray for health reasons than non-Hispanic whites. However, such details
regarding CAM use in African Americans with RA are lacking due to low representation of
African Americans in RA studies. Also, much of the CAM research in arthritis has been
focused on individuals with longstanding disease (7-9) and data on those with early disease
are lacking.
The results regarding sex differences with regard to CAM use in RA patients have been
mixed. Some studies report higher CAM use by women (6,10,11), while others report no
significant sex differences (7,12). Arcury et al (8) reported that women were less likely to
drink liquor (whiskey) and more likely to use religion as a remedy for their arthritis-related
symptoms. Such sex differences, which could be due to differential disease activity, are of
clinical significance, reflecting sex-specific health behaviors.
The purpose of this study was to describe the prevalence of CAM use with regard to various
treatments, activities, and providers using a cohort of African Americans with RA from the
southern US. The study also examined potential differences by sex and disease duration with
regard to overall and specific CAM use.
Significance & Innovations
• Use of complementary and alternative medicine (CAM) is very common in
chronic conditions such as arthritis, but little is known about its use in African
American patients with rheumatoid arthritis (RA). This study describes specifics
of CAM medications, activities, and providers, as well as factors associated with
their use in a unique large cohort of African Americans with RA, with both
early and longstanding disease.
• Our study found that CAM use was highly prevalent in this cohort, even in
individuals with early disease. Significant sex differences were found with
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regard to specific CAM use. The majority of participants sought care from both
conventional and CAM providers and used both conventional medicines and
CAM treatments/activities to relieve RA-related symptoms, anxiety, and stress.
• These findings have important implications for delivery of health care for
African Americans with chronic diseases.
PATIENTS AND METHODS
Study population
The data source for this analysis was the National Institute of Arthritis and Musculoskeletal
and Skin Diseases–funded Consortium for the Longitudinal Evaluation of African
Americans with Early Rheumatoid Arthritis (CLEAR) Registry. The registry enrolled self-
declared African Americans with a diagnosis of RA as defined by the revised (1987)
American College of Rheumatology classification criteria (9). The registry has 2 arms:
longitudinal (CLEAR I, 2000–2005) and cross-sectional (CLEAR II, 2006–2012). In
CLEAR I, patients with disease duration of <2 years were enrolled; in CLEAR II, patients
with any disease duration were enrolled. In addition to the enrollment visit in CLEAR I,
participants were followed at 36 months and at 60 months post–disease onset, while the
CLEAR II participants had only 1 enrollment visit. Comprehensive demographic, clinical,
and radiographic data were obtained at each visit. For this analysis, enrollment data from
both CLEAR I and II were analyzed. The registry was approved by the Institutional Review
Boards of the participating institutions: University of Alabama at Birmingham, Emory
University (Atlanta, Georgia), Medical University of South Carolina (Charleston),
University of North Carolina at Chapel Hill, and Washington University (St. Louis,
Missouri). Further details of the registry can be found at http://medicine.uab.edu/rheum/
70918/.
Outcome measures
The CLEAR registry database has self-reported data on 16 types of CAM treatments, 9
CAM activities, and 5 CAM providers (Tables 1, 2, and 3). The participants were asked
about CAM use specific to the RA-related symptoms (treatments), anxiety, or stress
(activities). In addition to the CAM providers, participants were also asked if they consulted
conventional medical providers such as a rheumatologist, family doctor, orthopedist,
occupational therapist, podiatrist, and others. At the enrollment visit, participants were asked
about ever and recent (within the previous month) use of each CAM treatment and activity
and ever and past 6 months consultation with CAM provider(s).
Statistical analysis
Specific CAM (treatment, activity, and provider) use was described as ever use versus never
use. Additionally, overall CAM use was ascertained as follows: participants reporting ever
using any of the 16 CAM treatments were categorized as “ever users” of treatment, while
others were categorized as “never users.” Similar categorization was done for CAM
activities (using any of the 9 activities) and CAM providers (consulting any of the 5 CAM
providers). For disease duration the participants were stratified into those with early (<2
years) versus those with longer (>2 years) disease duration. The differences between the
dichotomized groups (per disease duration and sex) were examined using percentages and
chi-square tests. Corresponding univariate odds ratio (OR) and 95% confidence interval
(95% CI) for ever versus never use of CAM was reported using logistic regression.
Continuous variables were reported as means with SDs or medians with quartiles and
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compared using t-test or Wilcoxon’s rank sum (nonparametric) test. Statistical significance
was set at 0.05 (2-tailed).
RESULTS
Of the 855 participants included in the analysis, 85% were females and 418 (48.9%) had
early disease (Table 4). Data on self-reported comorbidities were available for 814
participants; 23.7% reported having diabetes mellitus, 13.0% heart disease, 67.2%
hypertension, and 5.0% stroke. Significant differences were found between those with
longer duration versus those with early disease duration, age at RA onset and enrollment (P
< 0.001), marital status (P = 0.02), pain (P = 0.03), median tender joints (P = 0.01),
radiographic erosions of the hands/feet (P < 0.001), radiographic joint space narrowing of
the hands and feet (P < 0.001), comorbidity (self-reported diabetes mellitus, hypertension,
heart disease, or stroke) count (P = 0.001), and medication use (P < 0.001) (Table 4). There
were significant differences between men and women with regard to educational level (P <
0.001), marital status (P = 0.004), smoking (P < 0.001), alcohol use (P < 0.001), obesity (P
< 0.001), Health Assessment Questionnaire score (P = 0.04), joint tenderness (P = 0.002),
and number of swollen joints (P = 0.02).
Overall CAM use
Of the 855 participants, 849 participants (99%) had used at least 1 of the CAMs (treatment
or activity or provider) with the following distribution: 95% ever used any of the 16
treatments, 98% ever used any of the activities, and 51% ever used a CAM provider (Table
5). When prayer was excluded from the analyses, the prevalence of ever use of activity was
97%. Past-month use (indicating recent/current use) of any of the treatments was reported by
73% of participants and use of any of the activities by 97% of participants (95% for without
prayer).
Of the 855 participants, 438 (51%) had ever sought care from a CAM provider, while 417
did not (Table 5). Of the 438 participants who had ever sought care from a CAM provider,
99.5% had also used various treatments and/or activities, and almost all (n = 437) had also
consulted other medical providers for their arthritis-related symptoms. Similarly, of the 417
participants who had not ever sought care from a CAM provider, 98.6% had also used
various treatments and/or activities, and 99.0% had also consulted other medical providers.
Overall, the participants had tried (ever use) medians of 3 CAM treatments, 5 CAM
activities, and 1 CAM provider. Average past-month use of treatments and activities were 1
and 4, respectively. Similarly, the median number of CAM providers consulted in the past 6
months was lower (median 0).
Specific CAM use
Among the treatments, heat treatment (e.g., pads, hot baths, and paraffin) was the most
common (80%), followed by store-bought lotions/oils/creams (76%) (Table 1). Praying or
attending church services (92%) was the most common activity followed by talking to a
friend or family member (83%) (Table 2). Among the CAM providers, the most common
provider was a pastor, priest, rabbi, or other church leader (32%), followed by a chiropractor
(23%) (Table 3).
CAM use and disease duration
When late versus early disease groups were compared, no significant differences were found
with regard to CAM treatment, while statistically significant results were found for CAM
activity (Table 5). No significant differences were found with regard to ever consulting with
a CAM provider, while those with late disease were significantly less likely to have
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consulted a CAM provider in the last 6 months as compared to those with early disease
(Table 5). Those with longer disease duration had a higher number of treatments ever used
than those with early disease (median 4 versus 3; P < 0.001).
Those with longer disease duration were significantly more likely to have ever used raisins
soaked in vodka/gin (OR 2.7, 95% CI 1.2–6.2) and fish oils and/or omega-3 fatty acids (OR
2.2, 95% CI 1.6–3.1) than those with early disease (Table 1). Similar significant associations
were observed for using household oils, gelatin, or fruit pectin in grape/aloe vera juice, heat
treatment, wearing special jewelry, wearing magnets, and eating garlic (Table 1). Those with
longer disease duration were significantly more likely to drink alcoholic beverages to relieve
RA-related anxiety and stress than those with early disease (OR 2.0, 95% CI 1.5–2.8) (Table
2). Similar positive associations were observed for doing a favorite hobby, using
biofeedback, and thinking/visualizing something pleasant/positive (Table 2). With regard to
consulting a CAM provider, those with longer disease duration were more likely to consult a
chiropractor (OR 1.5, 95% CI 1.1–2.1) but less likely to consult a religious leader (OR 0.7,
95% CI 0.6–1.0) than those with early disease (Table 3).
CAM use and sex differences
No significant sex differences were found with regard to ever use of CAM treatment,
activity, or provider (Table 5). Women had (ever use) tried more CAM activities than men
(median 5 versus 4; P = 0.003). Women were significantly more likely to use heat
treatments (OR 1.8, 95% CI 1.2–2.8) while less likely to use household oils (OR 0.5, 95%
CI 0.3–0.8); no significant differences were found for other types of treatments (Table 1).
Significant sex differences were found with regard to all the activities. Women were
significantly more likely to use various CAM activities for RA treatment than men, except
for smoking and drinking alcoholic beverages (Table 2). With regard to CAM providers,
women were less likely to consult a chiropractor than men (OR 0.6, 95% CI 0.4 – 0.9)
(Table 3). No significant differences were found with regard to other providers, including
pastor/priest.
DISCUSSION
In this study, prevalence of ever CAM use was found to be higher than that reported in other
RA/arthritis studies (20–90%) (4,6,7,10-15), even in patients with early disease duration and
after excluding prayer as CAM. Higher CAM use found in this study could be due to the
number and/or type of CAM modalities asked in our questionnaire, which differed from
other studies. As CAMs are constantly changing, developing a standard questionnaire for
CAM use is difficult. For example, the number of therapies listed in the 2007 NHIS (3)
questionnaire increased to 36 compared to 27 used in the 2002 NHIS questionnaire. Thus,
the definition of CAM varies across studies and can change over time, with some CAM
modalities included in “usual” care of RA patients. Furthermore, it has been reported that
patients typically do not disclose the use of CAM to their health care providers for various
reasons (4,6,13-15). Therefore, it is possible that the estimates in various studies could
underestimate the “true” prevalence of CAM use.
Racial/ethnic differences with regard to CAM use have been reported in the US. The 2002
and 2007 NHIS found that when prayers were excluded from the definition of CAM, non-
Hispanic whites had a higher prevalence of using at least one CAM compared to Asian
Americans, African Americans, and Hispanics (4). However, when prayer was included in
the CAM definition, African Americans had the highest CAM prevalence. The previous US
national surveys have also found higher CAM prevalence among non-Hispanic whites than
other races/ethnicities (16-18). In RA patients as well, Herman et al (6) found that non-
Hispanic whites were significantly more likely to use CAM than Hispanics. In other studies
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that included a mix of various types of musculoskeletal syndromes such as RA,
osteoarthritis, and fibromyalgia, results have been mixed. Mikuls et al (7) found that non-
Hispanic whites were more likely to use CAM than African Americans, while Arcury et al
(8) and Katz and Lee (19) found that African Americans were more likely to use CAM than
non-Hispanic whites. In contrast, Rao et al (12) did not find race/ethnicity to be significantly
associated with regular use of CAM. The current study was an exclusive cohort of African
Americans and, therefore, racial/ethnic comparison could not be done. Nevertheless,
prevalence of CAM use found in this study is higher than found in other studies.
We did not specifically query activities such as going to a place of pilgrimage or praying to
specific entities (e.g., specific representations of a benevolent god or a holy saint). Most of
the participants were from an area of the country where there are not significant numbers of
Roman Catholics, particularly in the African American community. Similarly, meditation
was used frequently in almost 60% of our participants. We were unable to determine from
our data more detailed information on this; it is unclear based on our questionnaire whether
patients were instructed on meditation or self-taught, whether it was part of yoga or prayer,
or whether meditation was part of an independent set of activities. Similarly, we did not ask
about spa treatments. Approximately one-third of our participants met criteria for the
poverty level, so we speculate that going to a spa would not have been common among this
group of subjects.
The use of chiropractic or similar practitioners of non-traditional medicine deserves further
comment. According to the 2007 NHIS (3), approximately 8.6% of adults in the US had
received chiropractic or osteopathic manipulation in the 12 months prior to the interview. A
study by Shelke and Brook (20) analyzed data from the RAND Corporation Health
Insurance Experiment and found that of the 5,279 people enrolled, 7.5% sought chiropractic
care. A study by Feuerstein et al (21) examined the 1997 National Medical Expenditure
Survey and found that 9% of the population had used physical therapy. A review by
Lawrence and Meeker (22) of chiropractic use for chronic low back pain and other
conditions reported a prevalence ranging from 6–12%. Other surveys (16,18,23-26) found
that the annual prevalence of chiropractic use ranges from 6.8–16% in the US population.
This range could be attributed in part to differences in racial/ethnic groups, time periods
under study, or differences in study designs. The NHIS figures of acupuncture use are
similar to the prevalence reported in our study.
Geographic location has also been cited as one of the reasons for disparity; national studies
among general populations have found higher CAM use in the western region compared to
other regions of the US (6,15,17). The current study participants were from Alabama,
Georgia, Missouri, North Carolina, and South Carolina, and no differences in CAM use by
site were found. The study populations in the current and other RA studies (6,11-13,27) did
not differ with regard to health care setting, as the participants were recruited from
university-based clinics. Of note, however, is that the other studies’ participants were
predominantly non-Hispanic whites and arthritis-related studies have reported higher use of
CAM among African Americans than non-Hispanic whites (8,19). As the studies differ in
their definitions of CAM and overall study population, comparison between the studies
should be made with caution.
Current evidence regarding efficacy of various CAM modalities is limited and inconsistent.
A recent systematic review (28) identified 218 CAM modalities used in rheumatic diseases.
However, randomized clinical trials of RA were available for only 18 CAMs and produced
inconsistent results. Only borage seed oil and thunder god vine trials were positive; the
review did not include fish oil (omega-3 polyunsaturated fatty acid) as another meta-analysis
(29) had shown its beneficial effect in reducing pain, duration of morning stiffness, and
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number of tender/swollen joints. Another review by Efthimiou and Kukar (30) concluded
that acupuncture, herbal medicines, dietary omega-3 polyunsaturated fatty acid, vitamins,
and pulsed electromagnetic field showed “promising” efficacy in reducing pain. While some
of the beneficial CAMs such as fish oils were used by the study participants, potentially
harmful remedies such as WD-40 and turpentine were also used. Furthermore, some
remedies could have interactions with conventional medicines or could lead to deferral of
effective therapies (8,30-33). Although CAMs are generally considered safe, serious side
effects have been reported. Therefore, it is important for a physician to be knowledgeable of
the safety profile and mechanism of action of the used CAM.
On average in this study, patients tried 3 treatments, 5 activities, and consulted at least 1
CAM provider. Various treatments and some activities, such as biofeedback, would incur
some out-of-pocket financial expenditure. Although this study did not specifically examine
this issue, financial costs associated with CAM use are escalating. It is estimated that in
1990, US patients spent approximately $13.7 billion on various CAM modalities, which
increased to $21.2 billion in 1997. A total of $5.1 billion was spent on herbal medicines, and
out-of-pocket expenses on CAMs totaled $12.2 billion (18).
Being aware of CAM use, health care providers can advise patients regarding potentially
beneficial, harmful, or ineffective treatments. This would also help in overall management
and could address the issues of treatment adherence and outcomes. While it has been
reported that patients typically do not disclose the use of CAM to their health care providers
(6,12,18,34,35), a high proportion of (self-reported) CAM use in this study indicates
willingness of the patients to disclose the practices regarding CAM use for research
purposes.
This study did not find significant sex differences for overall CAM use, although women
tried more CAM activities than men (median 5 versus 4). The tendency to use more
activities could indicate that women have more RA-related anxiety and stress than men.
Studies regarding sex differences in CAM use have produced mixed results; some report
higher CAM use by women (6,10,11), while others report no significant sex differences
(7,12). Although no significant sex differences were found in this study with regard to
overall CAM use, specific treatments and activities did vary among men and women.
Women were significantly less likely to use household oils, smoke, or drink alcoholic
beverages for RA treatment, but they were more likely to use heat treatments, pray, write in
a journal, and participate in hobby activities. Arcury et al (8) also found that women were
less likely to drink alcoholic beverages and were more likely to pray or attend church
services.
There are several limitations to our study. The cross-sectional study design precluded
definitively establishing a cause and effect relationship. We could not conduct multivariable
analyses due to high prevalence of CAM use leading to highly unbalanced groups of CAM
users versus nonusers. Another limitation of the study was that the CAM practices were self-
reported. However, self-report is likely the most feasible and appropriate way of collecting
data on CAM. Our study forms had specific close-ended questions regarding CAM use and
no open-ended questions or “other” practices were asked. It is possible that the patients
could have used other CAM modalities not covered in the study form, which is a limitation
of this study. However, there is no standard questionnaire regarding CAM use and the items
included in our study forms were based on previous work and covered major areas/
categories of CAM use. Given the high prevalence of CAM use reported in this study and
the wide range of items queried, we expect that prevalence of “other” CAM modalities
would have been small compared to the items included in the forms.
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This is the first study of an exclusively African American cohort with RA. Our sample size
of African Americans is much larger than other studies, which have typically included a
small proportion of African Americans. Our results are likely specific to African Americans
and not to RA patients of other races/ethnicities. Unlike other studies (7,10,13,14,36,37), the
cohort was exclusively of RA patients rather than a mix of rheumatic conditions (e.g.,
osteoarthritis, fibromyalgia). Quandt et al (10) noted that most published studies fail to
differentiate whether the individual’s CAM use is arthritis-related or for other purposes,
which makes it difficult for clinicians to understand which therapies are chosen for arthritis.
In this study, we reported CAM use specifically for RA-related symptoms or associated
anxiety and stress.
In conclusion, CAM use was high in this cohort of African Americans with RA. Health care
providers should be cognizant of CAM use as some treatments could interact with
conventional medicines and have a differential impact on African Americans, where racial
disparities are known to affect access to conventional care.
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Table 1



























 Ever use 684 (80.3) 84.4 75.9 0.002‡ 1.7 (1.2–2.4)‡ 81.9 71.3 0.01‡ 1.8 (1.2–2.8)‡
 Past month 413 (48.6) 47.2 50.0 50.3 39.1
Store-bought lotions, oils, creams
 Ever use 651 (76.3) 78.7 73.8 0.09 1.3 (1.0–1.8) 77.2 72.9 0.28 1.3 (0.8–1.9)
 Past month 295 (34.6) 33.7 64.4 35.3 31.0
Cold treatments (e.g., ice packs)
 Ever use 245 (28.7) 31.4 25.9 0.08 1.3 (1.0–1.8) 29.7 23.3 0.14 1.4 (0.9–2.2)
 Past month 105 (12.4) 12.7 12.0 12.9 9.3
Apple cider vinegar, cranberry juice/
honey
 Ever use 242 (28.4) 30.4 26.2 0.17 1.2 (0.9–1.7) 28.3 29.5 0.78 0.9 (0.6–1.4)
 Past month 159 (18.7) 19.5 17.8 18.7 18.8
Special jewelry (e.g., copper chain)
 Ever use 231 (27.2) 32.2 22.0 0.001‡ 1.7 (1.2–2.3)‡ 27.3 27.3 0.99 1.0 (0.7–1.5)
 Past month 91 (10.7) 10.8 10.6 11.1 8.5
Fish oils and/or omega-3 fatty acids
 Ever use 182 (21.3) 27.7 14.7 < 0.001‡ 2.2 (1.6–3.1)‡ 22.1 18.6 0.38 1.2 (0.8–2.0)
 Past month 94 (11.0) 14.4 7.5 11.3 9.3
Garlic
 Ever use 163 (19.2) 22.6 15.7 0.01‡ 1.6 (1.1–2.2)‡ 20.2 14.0 0.10 1.6 (0.9–2.6)
 Past month 110 (13.0) 14.3 11.6 13.6 9.3
Store-bought herbal/plant oils/creams
 Ever use 163 (19.2) 20.8 17.4 0.20 1.2 (0.9–1.8) 20.3 14.7 0.14 1.5 (0.9–2.5)
 Past month 95 (11.1) 11.4 10.8 11.4 9.3
Glucosamine sulfate and/or
chondroitin sulfate
 Ever use 160 (18.8) 21.1 16.5 0.09 1.3 (1.0–1.9) 19.3 16.3 0.42 1.2 (0.7–2.0)
 Past month 59 (6.9) 7.8 6.0 7.2 5.4
Gelatin/fruit pectin in grape/aloe vera
juice
 Ever use 128 (15.1) 18.5 11.5 0.005‡ 1.7 (1.2–2.6)‡ 15.8 13.2 0.45 1.2 (0.7–2.1)
 Past month 58 (6.8) 6.7 7.0 6.8 7.0
Household oils (e.g., WD-40 or
turpentine)
 Ever use 125 (14.7) 18.2 11.0 0.003‡ 1.8 (1.2–2.7)‡ 13.3 22.7 0.01‡ 0.5 (0.3–0.8)‡






































 Past month 26 (3.1) 3.4 2.6 2.6 5.5
Other herbs or herbal drinks
 Ever use 118 (13.9) 13.6 14.1 0.82 1.0 (0.6–1.4) 13.6 16.3 0.41 0.8 (0.5–1.3)
 Past month 70 (8.2) 7.4 9.1 9.0 3.9
Homemade oils or other oils/lotion/
rubs
 Ever use 96 (11.3) 12.2 10.4 0.41 1.2 (0.8–1.8) 11.5 11.8 0.91 1.0 (0.5–1.7)
 Past month 53 (6.2) 6.0 6.5 6.1 7.0
Magnets
 Ever use 90 (10.6) 12.8 8.2 0.03‡ 1.7 (1.1–2.6)‡ 11.0 7.8 0.28 1.5 (0.7–2.9)
 Past month 26 (3.1) 2.5 3.6 3.3 1.6
Other food/drink, including home
remedies
 Ever use 57 (6.7) 7.4 6.0 0.43 1.2 (0.7–2.1) 6.8 6.2 0.81 1.1 (0.5–2.4)
 Past month 34 (4.0) 3.9 4.1 4.1 3.1
Raisins soaked in vodka or gin
 Ever use 30 (3.5) 5.0 1.9 0.02‡ 2.7 (1.2–6.2)‡ 3.6 3.1 0.78 1.2 (0.4–3.4)
 Past month 9 (1.1) 1.4 0.7 1.1 0.8
*
Values are the number (percentage) or the percentage unless indicated otherwise. Reference category is “never use.” Wherever applicable,
participants with “unknown” and “refused to answer” responses were excluded from calculating percentages. CAM = complementary and
alternative medicine; RA = rheumatoid arthritis; CLEAR = Consortium for the Longitudinal Evaluation of African Americans with Early




Statistically significant at the 0.05 level.
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Table 2

























 Ever use 785 (92.2) 93.1 91.3 0.33 1.3 (0.8–2.1) 93.9 82.9 < 0.001‡ 3.2 (1.8–5.5)‡
 Past month 735 (87.2) 88.4 86.0 89.1 76.6
Talk to a friend/family member
 Ever use 718 (84.3) 82.2 86.5 0.08 0.7 (0.5–1.0) 85.6 77.3 0.02‡ 1.7 (1.1 –2.8)‡
 Past month 685 (81.1) 78.1 84.2 82.3 74.2
Think or visualize something
pleasant/positive
 Ever use 672 (79.3) 82.4 76.2 0.03‡ 1.5 (1.0–2.0)‡ 81.5 68.0 0.001‡ 2.1 (1.4–3.2)‡
 Past month 651 (77.4) 79.9 74.8 79.6 65.1
Do a favorite hobby
 Ever use 522 (61.5) 66.8 55.9 0.001‡ 1.6 (1.2–2.1)‡ 63.4 51.2 0.01‡ 1.7 (1.1–2.4)‡
 Past month 455 (54.0) 56.0 52.0 56.1 42.6
Meditate
 Ever use 507 (59.5) 62.6 56.3 0.06 1.3 (1.0–1.7) 62.1 45.7 0.001‡ 1.9 (1.3–2.8)‡
 Past month 467 (55.2) 57.8 52.4 57.8 40.6
Smoke tobacco/other substance
 Ever use 287 (33.8) 36.9 30.7 0.06 1.3 (1.0–1.8) 31.1 51.2 < 0.001‡ 0.4 (0.3–0.6)‡
 Past month 217 (25.5) 23.9 27.2 22.1 45.0
Drink alcohol
 Ever use 221 (26.0) 32.3 19.3 < 0.001‡ 2.0 (1.5–2.7)‡ 24.8 34.1 0.03‡ 0.6 (0.4–0.9)‡
 Past month 122 (14.3) 15.8 12.7 12.9 22.5
Use biofeedback
 Ever use 157 (18.5) 21.9 15.0 0.01‡ 1.6 (1.1–2.3)‡ 20.4 8.6 0.002‡ 2.7 (1.4–5.2)‡
 Past month 135 (15.9) 18.6 13.0 17.6 6.3
Write in a journal
 Ever use 136 (16.0) 15.7 16.3 0.79 1.0 (0.7–1.4) 18.0 5.4 < 0.001‡ 3.2 (1.7–8.4)‡
 Past month 93 (11.0) 10.0 12.0 12.1 4.7
*
Values are the number (percentage) or the percentage unless indicated otherwise. Reference category is “never use.” CAM = complementary and
alternative medicine; RA = rheumatoid arthritis; CLEAR = Consortium for the Longitudinal Evaluation of African Americans with Early




Statistically significant at the 0.05 level.
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Table 3





















Pastor, priest, or other
church leader
 Ever seen 270 (31.8) 28.5 35.3 0.03‡ 0.7 (0.5–1.0)‡ 32.1 30.2 0.68 1.1 (0.7–1.6)
 Seen in last 6 months 227 (26.7) 21.8 31.8 27.0 24.8
Chiropractic doctor
 Ever seen 195 (22.8) 26.4 19.2 0.01‡ 1.5 (1.1–2.1)‡ 21.6 30.2 0.03‡ 0.6 (0.4–0.9)‡
 Seen in last 6 months 36 (4.2) 3.9 4.6 3.7 7.0
Massage therapist
 Ever seen 72 (8.5) 8.5 8.5 0.97 1.0 (0.6–1.6) 8.8 7.0 0.50 1.3 (0.6–2.6)
 Seen in last 6 months 36 (4.3) 3.9 4.6 4.2 4.7
Acupuncturist
 Ever seen 42 (4.9) 5.5 4.3 0.43 1.3 (0.7–2.4) 4.9 5.4 0.78 0.9 (0.4–2.0)
 Seen in last 6 months 8 (0.9) 0.5 1.4 0.8 1.6
Herbalist
 Ever seen 36 (4.2) 4.4 4.1 0.84 1.1 (0.5–2.1) 4.2 4.7 0.80 0.9 (0.4–2.2)
 Seen in last 6 months 15 (1.8) 1.4 2.2 1.7 2.3
*
Values are the number (percentage) or the percentage unless indicated otherwise. Reference category is “never use.” CAM = complementary and
alternative medicine; RA = rheumatoid arthritis; CLEAR = Consortium for the Longitudinal Evaluation of African Americans with Early




Statistically significant at the 0.05 level.
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Table 4
















Age at RA onset, mean :± SD years 47.3 :± 13.3 44.2 :± 12.7 50.5 :± 13.3 47.1 :± 13.5 48.1 :± 12.2
Age at enrollment, mean :± SD years 54.3 :± 12.7 57.0 :± 11.6 51.5 :± 13.2 54.3 :± 12.9 54.3 :± 11.9
Early disease (<2 years), % 48.9 – – 48.3 51.9
Women, % 84.9 85.8 84.0 – –
Education (2 high-school degree), % 75.3 76.0 74.6 77.7 62.0
Married, % 29.2 25.6 32.9 27.3 39.8
Poverty level, % 34.1 35.9 32.2 34.8 29.9
Ever smoker, % 51.7 51.3 52.2 48.1 72.1
Ever drank alcohol, % 66.6 67.1 66.1 64.1 80.5
Obese (BMI 230 kg/m2), % 52.4 53.1 51.6 55.1 37.3
DAS28-CRP, mean :± SD 3.9 :± 1.4 3.7 :± 1.4 3.9 :± 1.5 3.9 :± 1.4 3.7 :± 1.5
HAQ score, median (Q1,Q3) 1.4 (0.8, 1.9) 1.4 (0.8, 1.9) 1.4 (0.8, 1.9) 1.4 (0.8, 1.9) 1.1 (0.8, 1.8)
Pain score (0–10), median (Q1,Q3) 7 (4, 8) 7 (5, 8) 6 (4, 8) 7 (4, 8) 7 (5, 9)
Fatigue score (0–10), median (Q1,Q3) 6 (3, 8) 6 (4, 8) 6 (3, 8) 6 (3, 8) 5 (3, 8)
Helplessness score, median (Q1,Q3)† 2.8 (2.0, 3.6) 2.8 (2.0, 3.4) 2.8 (2.0, 3.6) 2.8 (2.0, 3.6) 2.8 (2.0, 3.6)
Tender 28 joints, median (Q1,Q3) 4 (1, 11) 4 (1, 9) 5 (2, 13) 5 (2, 11) 4 (0, 9)
Tender 28 joints (>0),% 83.3 82.3 84.2 85.0 73.6
Swollen joints, median (Q1,Q3) 4 (1, 9) 4 (1, 9) 3 (1, 8) 4 (1, 9) 3 (0, 7)
Swollenjoints (>0), % 76.8 76.6 77.0 78.2 69.0
Erosion, median (Q1,Q3) 0 (0, 5) 2 (0, 14) 0 (0, 1) 0 (0, 4.5) 0 (0, 5)
Erosion (>0), % 42.8 56.0 28.2 41.9 47.4
Narrowing, median (Q1,Q3) 0 (0, 10) 6 (0, 26) 0 (0, 0) 0 (0, 9.5) 0 (0, 10.5)
Narrowing (>0), % 42.1 61.6 20.7 41.0 48.3
Comorbidity (21), %‡ 71.1 65.4 76.5 71.2 70.7
Ever use DMARDs, % 90.7 96.8 84.4 90.2 93.8
Ever use methotrexate, % 74.1 83.1 64.7 74.4 72.7
Ever use steroids, % 89.8 94.1 83.4 90.3 86.1
*
Wherever applicable, “unknown” data were excluded. RA = rheumatoid arthritis; CLEAR = Consortium for the Longitudinal Evaluation of
African Americans with Early Rheumatoid Arthritis; BMI = body mass index; DAS28-CRP = Disease Activity Score based on tenderness and
swelling of 28 joints with C-reactive protein (CRP); HAQ = Health Assessment Questionnaire; Q1,Q3 = first quartile, third quartile; DMARDs =
disease-modifying antirheumatic drugs (including biologic agents).
†
Using Rheumatology Attitudes Index.
‡
Self-reported (diabetes mellitus, hypertension, heart disease, stroke).













TAMHANE et al. Page 16
Table 5




















 Ever 812 (95.0) 418 (95.7) 394 (94.3) 0.35 1.3 (0.7–2.5) 692 (95.3) 120 (93.0) 0.27 1.5 (0.7–3.3)
 Past month 626 (73.2) 322 (73.7) 304 (72.7) 541 (74.5) 85 (65.9)
Activity§
 Ever 839 (98.1) 434 (99.3) 405 (96.9) 0.01¶ 4.6 (1.3–16.4)¶ 714 (98.4) 125 (96.9) 0.28 1.9 (0.6–6.0)
 Past month 830 (97.1) 430 (98.4) 400 (95.7) 707 (85.2) 123 (95.4)
Provider#
 Ever 438 (51.2) 223 (51.0) 215 (51.4) 0.91 1.0 (0.8–1.3) 371 (51.1) 67 (51.9) 0.86 1.0 (0.7–1.4)
 Past 6 months 274 (32.0) 119 (27.2) 155 (37.1) 233 (32.1) 41 (31.8)
*
Values are the number (percentage) unless indicated otherwise. CAM = complementaryand alternative medicine; RA = rheumatoidarthritis;





Used at least 1 of the 16 treatments.
§
Used at least 1 of the 9 activities.
¶
Statistically significant at the 0.05 level.
#
Consulted at least 1 of the 5 CAM providers.
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